Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Grimison

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Review of Anticancer Therapy|November 22, 2007
Quality of life and adjuvant systemic therapy for early-stage breast cancerPeter S Grimison, Martin R Stockler
BMC Cancer|May 6, 2006
Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four casesPeter S Grimison, Melvin T Chin, Michelle L Harrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancerPeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Deriving a patient-based utility index from a cancer-specific quality of life questionnairePeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Frontiers in Oncology|May 17, 2023
Quantitative proteomic studies addressing unmet clinical needs in sarcomaElizabeth A Connolly, Peter S Grimison, Lisa G Horvath, et al.
ANZ Journal of Surgery|September 19, 2012
Factors delaying chemotherapy for breast cancer in four urban and rural oncology unitsPeter N Fox, Mark D Chatfield, Jane M Beith, et al.
Cancer Treatment Reviews|December 1, 2023
A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working partyDeborah Di-Xin Zhou, Elizabeth A Connolly, Jasmine Mar, et al.
Cancer Medicine|May 23, 2022
Mesenchymal chondrosarcoma: An Australian multi-centre cohort studyMadeleine C Strach, Peter S Grimison, Angela Hong, et al.
Patient Related Outcome Measures|November 15, 2014
Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approachDaniel Sj Costa, Neil K Aaronson, Peter M Fayers, et al.
Journal of the National Cancer Institute|July 16, 2010
Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trialPeter S Grimison, Martin R Stockler, Damien B Thomson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Review of Anticancer Therapy|November 22, 2007
Quality of life and adjuvant systemic therapy for early-stage breast cancerPeter S Grimison, Martin R Stockler
BMC Cancer|May 6, 2006
Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four casesPeter S Grimison, Melvin T Chin, Michelle L Harrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancerPeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Deriving a patient-based utility index from a cancer-specific quality of life questionnairePeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Frontiers in Oncology|May 17, 2023
Quantitative proteomic studies addressing unmet clinical needs in sarcomaElizabeth A Connolly, Peter S Grimison, Lisa G Horvath, et al.
ANZ Journal of Surgery|September 19, 2012
Factors delaying chemotherapy for breast cancer in four urban and rural oncology unitsPeter N Fox, Mark D Chatfield, Jane M Beith, et al.
Cancer Treatment Reviews|December 1, 2023
A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working partyDeborah Di-Xin Zhou, Elizabeth A Connolly, Jasmine Mar, et al.
Cancer Medicine|May 23, 2022
Mesenchymal chondrosarcoma: An Australian multi-centre cohort studyMadeleine C Strach, Peter S Grimison, Angela Hong, et al.
Patient Related Outcome Measures|November 15, 2014
Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approachDaniel Sj Costa, Neil K Aaronson, Peter M Fayers, et al.
Journal of the National Cancer Institute|July 16, 2010
Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trialPeter S Grimison, Martin R Stockler, Damien B Thomson, et al.
Pageof 2